Background. The approach to the treatment of patients with primary open-angle glaucoma and cataract is still a subject of debate, because when choosing a particular type of procedure, as well as determining the timing of its performance, it is necessary to consider a significant number of factors that may affect success of treatment. There are limited data on the outcomes of combined treatment of patients with primary open-angle glaucoma and complicated cataract, which includes phacoemulsification with intraocular lens (IOL) implantation and micropulse transscleral cyclophotocoagulation (MP-TSCPC). The purpose is to compare efficacy and to study the nature and frequency of complications when using novel, two-stage and combined surgical and laser methods for treating primary open-angle glaucoma with cataract. Materials and methods. The study includes 112 patients (112 eyes) with primary open-angle glaucoma stage I–IV and complicated cataract. There were 3 observation groups. In the first one (n = 34), phacoemulsification with IOL implantation was performed 1 month prior to MP-TSCPC. The second group (n = 36) included patients who underwent phacoemulsification with IOL implantation a month after MP-TSCPC. In the third group (n = 42), phacoemulsification with IOL implantation and MP-TSCPC were performed in one procedure. These groups did not statistically differ in terms of age, gender, baseline intraocular pressure, stage of primary open-angle glaucoma and nuclear lens density. The primary outcome measure was the normalization of intraocular pressure with or without the use of antiglaucoma medications and without need for repeated laser and incisional procedures after 1, 3 and 6 months. The secondary outcome measure was stabilization or expansion of visual fields 1, 3, and 6 months after treatment. The complication nature and rates were evaluated. Results. In the third group, where combined treatment was performed, the incidence of transient hypertension and inflammatory complications was statistically higher. There was a tendency to a higher incidence of corneal edema, cystoid macular edema, and hypotony as well; 7.1 % of patients required repeated MP-TSCPC, but this was statistically insignificant. According to the survival analysis, a statistically significant difference was found between the three groups in functional (p = 0.036) and hypotensive outcomes (p = 0.046), with the best result in the second group at 6 months of follow-up. Conclusions. The efficacy assessed by hypotensive and functional outcomes at a follow-up period of 6 months appeared to be statistically lower in the group of combined treatment compared to the groups in which two-stage treatment was conducted.
Read full abstract